News | May 15, 2013

Three Key Questions on Breast-Specific Gamma Imaging for Breast Cancer

Report looks at sensitivity of BSGI for screening and diagnosis of breast cancer

May 15, 2013 — ECRI Institute released a report listing three key questions and the answers concerning breast-specific gamma imaging (BSGI; sometimes referred to as molecular breast imaging or MBI). The technology uses a specially designed gamma camera system to image the uptake of a tracer that emits gamma radiation (most commonly 99mtechnetium-sestamibi [MIBI]). MIBI is preferentially taken up by cancer tissue, and thus BSGI can be used to image breast cancer for a variety of clinical indications. Unlike X-ray mammography, BSGI is not affected by the density of breast tissue, and therefore it may be particularly useful for screening and diagnosis of breast cancer in women with dense breast tissue.

Indications for BSGI may include patients with dense breast tissue, difficult-to-interpret mammograms, implants, palpable lesions not detected by mammography, multiple suspicious or indeterminate lesions, pre-biopsy evaluation of suspect areas, disease staging for breast conservation surgery, and evaluation of post-surgical or post-therapeutic breasts. Contraindications are pregnancy and hypersensitivity to the tracer.

Regulatory Status
All three of the BSGI devices manufactured by Dilon Technologies (Newport News, Va.), Gamma Medica (Northridge, Calif.) and GE Healthcare (Wauwatosa, Wis.) have been cleared by the U.S. Food and Drug Administration (FDA) for marketing under the 510(k) process for diagnostic imaging of the breast as an adjunct to mammography.

State of the Evidence Base
ECRI searched 17 external and internal databases, including PubMed and Embase, through Nov. 7, 2012, for clinical trials on the use of BSGI for breast cancer.

Key Question 1: For what indications and patient populations has BSGI been clinically studied?
ECRI identified published studies of BSGI for screening asymptomatic women, for diagnostic workup, for pretreatment evaluation and for monitoring response to neoadjuvant therapy. They did not identify any published studies of BSGI for monitoring response to post-surgical treatment or for detecting recurrences of cancer.

Key Question 2: What is the accuracy of low-dose BSGI for screening the general population? For screening women with dense breast tissue?
Searches did not identify any studies of low-dose BSGI for screening that met our study inclusion criteria.

Key Question 3: What is the accuracy and utility of BSGI for pre-treatment workup? In comparison to other imaging technologies (such as MRI) for this indication?
Four studies of a total of 445 patients met inclusion criteria for analysis for this question. The crude mean diagnostic yields of occult lesions could be computed from the reported data. They rated the evidence as moderate in quality, but no robust analysis could be performed, and therefore they rated the evidence as insufficient to answer this question. Only one study reported on a direct comparison to MRI. Two studies reported information on the impact of BSGI on medical decision making; the most common impact was triggering additional imaging and biopsies, followed by changes to additional treatment plans or leading to more extensive surgical treatment.                               

ECRI Institute Conclusions
For diagnostic workup, the sensitivity of BSGI for distinguishing between malignant and benign lesions is approximately 92 percent. BSGI may be a valid option for a diagnostic workup in some women, particularly for women with dense breast tissue. However, the evidence available as of November 2012 was insufficient to evaluate the accuracy and utility of BSGI for any other breast screening, diagnostic, or monitoring applications.

For more information: 

Related Content

ASNC and SNMMI Release Joint Document on Diagnosis, Treatment of Cardiac Sarcoidosis
News | Cardiac Imaging | August 18, 2017
August 18, 2017 — The American Society of Nuclear Cardiology (ASNC) has released a joint expert consensus document wi
Houston Methodist Hospital Enters Multi-Year Technology and Research Agreement With Siemens Healthineers
News | Imaging | August 17, 2017
Houston Methodist Hospital and Siemens Healthineers have entered into a multi-year agreement to bring cutting-edge...
Study Demonstrates First Human Application of Novel PET Tracer for Prostate Cancer

Transaxial 11Csarcosine hybrid PET/CT showed a (triangulated) adenocarcinoma in the transition zone of the anterior right prostate gland on PET (A), CT (B), and a separately obtained T2?weighted MR sequence (C) with resulting PET/MRI registration (D). Image courtesy of M. Piert et al., University of Michigan, Ann Arbor, Mich.

News | Radiopharmaceuticals and Tracers | August 16, 2017
In the featured translational article in the August issue of The Journal of Nuclear Medicine, researchers at the...
Clinical Data Supports Use of Xoft System for Endometrial Cancer
News | Brachytherapy Systems | August 03, 2017
Researchers presented clinical data supporting use of the Xoft Axxent Electronic Brachytherapy (eBx) System for the...
The ASPIRE Cristalle FFDM system with DBT combines Fujifilm’s state-of-the-art hexagonal close pattern (HCP) detector design, advanced image processing and image acquisition workflow
News | Women's Health | August 01, 2017
Fujifilm Medical Systems U.S.A., Inc. announced that The Mammography Center of Monterey, an ACR-accredited breast...
Sponsored Content | Videos | Breast Imaging | July 28, 2017
Nancy Cappello, Ph.D., executive director and founder of Are You Dense Inc. and Are You Dense Advocacy, explains how
Radiotherapy Prior to Surgery Reduces Secondary Tumor Risk in Early-Stage Breast Cancer Patients
News | Radiation Therapy | July 24, 2017
Moffitt Cancer Center researchers launched a first-of-its-kind study comparing the long-term benefits of radiation...
Kubtec Launches New Website For Digital Imaging and Irradiation Products
News | Digital Radiography (DR) | July 20, 2017
Kubtec announced the launch a new website focused on the applications of digital X-ray imaging and irradiation for...
Overlay Init